Literature DB >> 24132877

Estimating twin concordance for bivariate competing risks twin data.

Thomas H Scheike1, Klaus K Holst, Jacob B Hjelmborg.   

Abstract

For twin time-to-event data, we consider different concordance probabilities, such as the casewise concordance that are routinely computed as a measure of the lifetime dependence/correlation for specific diseases. The concordance probability here is the probability that both twins have experienced the event of interest. Under the assumption that both twins are censored at the same time, we show how to estimate this probability in the presence of right censoring, and as a consequence, we can then estimate the casewise twin concordance. In addition, we can model the magnitude of within pair dependence over time, and covariates may be further influential on the marginal risk and dependence structure. We establish the estimators large sample properties and suggest various tests, for example, for inferring familial influence. The method is demonstrated and motivated by specific twin data on cancer events with the competing risk death. We thus aim to quantify the degree of dependence through the casewise concordance function and show a significant genetic component.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  casewise concordance; concordance function; cumulative incidence probability; multivariate competing risks; twins

Mesh:

Year:  2013        PMID: 24132877     DOI: 10.1002/sim.6016

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  7 in total

1.  Familial Risk and Heritability of Colorectal Cancer in the Nordic Twin Study of Cancer.

Authors:  Rebecca E Graff; Sören Möller; Michael N Passarelli; John S Witte; Axel Skytthe; Kaare Christensen; Qihua Tan; Hans-Olov Adami; Kamila Czene; Jennifer R Harris; Eero Pukkala; Jaakko Kaprio; Edward L Giovannucci; Lorelei A Mucci; Jacob B Hjelmborg
Journal:  Clin Gastroenterol Hepatol       Date:  2017-01-24       Impact factor: 11.382

2.  The heritability of prostate cancer in the Nordic Twin Study of Cancer.

Authors:  Jacob B Hjelmborg; Thomas Scheike; Klaus Holst; Axel Skytthe; Kathryn L Penney; Rebecca E Graff; Eero Pukkala; Kaare Christensen; Hans-Olov Adami; Niels V Holm; Elizabeth Nuttall; Steinbjorn Hansen; Mikael Hartman; Kamila Czene; Jennifer R Harris; Jaakko Kaprio; Lorelei A Mucci
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-05-08       Impact factor: 4.254

3.  The Danish Twin Registry: An Updated Overview.

Authors:  Dorthe Almind Pedersen; Lisbeth Aagaard Larsen; Marianne Nygaard; Jonas Mengel-From; Matt McGue; Christine Dalgård; Lars Hvidberg; Jacob Hjelmborg; Axel Skytthe; Niels V Holm; Kirsten Ohm Kyvik; Kaare Christensen
Journal:  Twin Res Hum Genet       Date:  2019-09-23       Impact factor: 1.587

4.  Danish cohort of monozygotic inflammatory bowel disease twins: Clinical characteristics and inflammatory activity.

Authors:  Frederik Trier Moller; Lina Knudsen; Marcus Harbord; Jack Satsangi; Hannah Gordon; Lene Christiansen; Kaare Christensen; Tine Jess; Vibeke Andersen
Journal:  World J Gastroenterol       Date:  2016-06-07       Impact factor: 5.742

5.  Sex differences in risk and heritability estimates on primary knee osteoarthritis leading to total knee arthroplasty: a nationwide population based follow up study in Danish twins.

Authors:  Søren Glud Skousgaard; Axel Skytthe; Sören Möller; Søren Overgaard; Lars Peter Andreas Brandt
Journal:  Arthritis Res Ther       Date:  2016-02-11       Impact factor: 5.156

Review 6.  Heritability in inflammatory bowel disease: from the first twin study to genome-wide association studies.

Authors:  Hannah Gordon; Frederik Trier Moller; Vibeke Andersen; Marcus Harbord
Journal:  Inflamm Bowel Dis       Date:  2015-06       Impact factor: 5.325

7.  Lifespans of Twins: Does Zygosity Matter?

Authors:  Jacob Hjelmborg; Pia Larsen; Jaakko Kaprio; Matt McGue; Thomas Scheike; Philip Hougaard; Kaare Christensen
Journal:  Genes (Basel)       Date:  2019-02-20       Impact factor: 4.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.